EUVIMEDEUVIMED entdecken
Crossref

Knockdown of RFC2 Prevents the Proliferation, Migration and Invasion of Cervical Cancer Cells

Jae Woong Koh, Seon-Joo Park

Anticancer Research · 2025

DOI: 10.21873/anticanres.17486 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Jae Woong Koh und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, College of Medicine, Chosun University, Gwangju, Republic of Korea. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Cell Movement, Replication Protein C. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Replication factor C subunit 2 (RFC2) is a component of the replication factor C (RFC) complex, which plays a critical role in DNA replication and repair. Recent studies have reported the involvement of RFC2 in several cancers. In this study, we investigated the functional role of RFC2 in cervical cancer progression. MATERIALS AND METHODS: RFC2 expression in cervical cancer cells was analyzed using quantitative real-time PCR (qRT-PCR) and western blotting. HeLa, ME-180, and SiHa cells were transfected with siRNAs targeting RFC2. Cell viability and proliferation were assessed using the MTT and colony formation assays, and cell cycle distribution was analyzed by flow cytometry. Migration and invasion abilities were evaluated through Transwell assays with or without Matrigel. RESULTS: RFC2 knockdown significantly reduced cell proliferation in cervical cancer cells. Flow cytometry analysis revealed cell cycle arrest at the S phase. Additionally, RFC2 knockdown markedly inhibited the migration and invasion of cervical cancer cells. These results demonstrate the critical involvement of RFC2 in regulating proliferation and metastatic potential in cervical cancer cells. CONCLUSION: RFC2 plays a pivotal role in promoting cervical cancer progression by enhancing cell growth, regulating the cell cycle, and promoting metastatic behavior. Further studies on the molecular mechanisms of RFC2 in cancer-associated pathways may provide a novel therapeutic target for developing cervical cancer treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsCell MovementReplication Protein CHumansFemaleCell ProliferationNeoplasm InvasivenessHeLa CellsGene Knockdown TechniquesCell Line, TumorGene Expression Regulation, NeoplasticRNA, Small Interfering

Stichwörter der Autor:innen

RFC2cervical cancerinvasionmigrationproliferation

Substanzen

Replication Protein CRNA, Small Interfering

Autor:innen und Institutionen

  • Department of Ophthalmology, College of Medicine, Chosun University, Gwangju, Republic of Korea.
  • Ophthalmic and Optic Medical Device Globalization Team, Ministry of Trade, Industry, and Energy, Chosun University, Gwangju, Republic of Korea.
  • Ophthalmic and Optic Medical Device Globalization Team, Ministry of Trade, Industry, and Energy, Chosun University, Gwangju, Republic of Korea; parksj@chosun.ac.kr.
  • Department of Premedical Science, College of Medicine, Chosun University, Gwangju, Republic of Korea.

Zitieren

APA

Koh, J. W., & Park, S. J. (2025). Knockdown of RFC2 Prevents the Proliferation, Migration and Invasion of Cervical Cancer Cells. Anticancer Research. https://doi.org/10.21873/anticanres.17486

Vancouver

Koh JW, Park SJ. Knockdown of RFC2 Prevents the Proliferation, Migration and Invasion of Cervical Cancer Cells. Anticancer Research. 2025. doi:10.21873/anticanres.17486

BibTeX
@article{Koh2025,
  author = {Koh, Jae Woong and Park, Seon-Joo},
  title = {Knockdown of RFC2 Prevents the Proliferation, Migration and Invasion of Cervical Cancer Cells},
  journal = {Anticancer Research},
  year = {2025},
  doi = {10.21873/anticanres.17486}
}
Kostenlos starten →